Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic bone marrow mesenchymal stromal cells (IVIC)
- Development stage
- Unknown
- Lead developer
- Instituto Venezolano de Investigaciones Científicas
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Topical
01
Overview
Allogeneic bone marrow mesenchymal stromal cells (IVIC) is an investigational cell therapy being developed by the Instituto Venezolano de Investigaciones Cientificas (IVIC) for the treatment of periodontal disease. The therapy consists of allogeneic bone marrow-derived mesenchymal stromal cells (MSCs) that are cultured and seeded onto a collagen scaffold, which is then incorporated into an autologous platelet-rich plasma (PRP) clot. This biological construct is surgically implanted into periodontal bone defects to promote the regeneration of alveolar bone, periodontal ligament, and cementum. The treatment aims to restore tissues destroyed by periodontal disease through the differentiation and paracrine signaling of the MSCs. It is currently being evaluated in a Phase 1/2 clinical trial to assess its safety and bone regeneration capacity.
- Other names
- Transplantation of allogeneic MSCs in periodontal diseaseAllogeneic MSCs for Bone Regeneration in Periodontal DiseaseAllogeneic bone marrow mesenchymal stromal cells
Beyond the preview
Go deeper on allogeneic bone marrow mesenchymal stromal cells (IVIC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic bone marrow mesenchymal stromal cells (IVIC).